| Primary |
| Colorectal Cancer |
35.0% |
| Colon Cancer |
14.9% |
| Colorectal Cancer Metastatic |
11.1% |
| Product Used For Unknown Indication |
8.4% |
| Drug Use For Unknown Indication |
5.9% |
| Prophylaxis |
4.1% |
| Rectal Cancer |
3.6% |
| Colon Cancer Metastatic |
2.8% |
| Prophylaxis Of Nausea And Vomiting |
1.9% |
| Gastrooesophageal Cancer |
1.9% |
| Large Intestine Carcinoma |
1.7% |
| Hypertension |
1.5% |
| Metastases To Liver |
1.3% |
| Breast Cancer |
1.2% |
| Cancer Pain |
1.1% |
| Constipation |
1.1% |
| Pain |
0.7% |
| Diabetes Mellitus |
0.6% |
| Neoplasm Malignant |
0.6% |
| Premedication |
0.6% |
|
| Rash |
21.2% |
| Skin Toxicity |
9.1% |
| Death |
6.9% |
| Hypomagnesaemia |
6.7% |
| Vomiting |
6.1% |
| Skin Reaction |
5.6% |
| Interstitial Lung Disease |
5.2% |
| Folliculitis |
4.5% |
| Dermatitis Acneiform |
3.4% |
| Stomatitis |
3.3% |
| Diarrhoea |
3.1% |
| Rash Pustular |
3.1% |
| Pulmonary Embolism |
3.0% |
| Dyspnoea |
2.8% |
| Febrile Bone Marrow Aplasia |
2.8% |
| Pyrexia |
2.8% |
| Infusion Related Reaction |
2.7% |
| Renal Failure |
2.5% |
| Skin Ulcer |
2.5% |
| Urinary Tract Infection |
2.5% |
|
| Secondary |
| Rectal Cancer |
41.0% |
| Colon Cancer |
28.9% |
| Colorectal Cancer |
8.5% |
| Prophylaxis |
3.7% |
| Prophylaxis Of Nausea And Vomiting |
2.7% |
| Metastases To Liver |
2.3% |
| Colorectal Cancer Metastatic |
2.0% |
| Colon Cancer Metastatic |
1.6% |
| Large Intestine Carcinoma |
1.2% |
| Rectal Cancer Recurrent |
1.2% |
| Hypertension |
0.9% |
| Rectal Cancer Metastatic |
0.9% |
| Benign Prostatic Hyperplasia |
0.8% |
| Duodenal Ulcer |
0.8% |
| Metastases To Lung |
0.7% |
| Product Used For Unknown Indication |
0.7% |
| Premedication |
0.6% |
| Anaemia |
0.6% |
| Metastases To Peritoneum |
0.6% |
| Constipation |
0.5% |
|
| White Blood Cell Count Decreased |
13.3% |
| Vaginal Laceration |
10.1% |
| Stomatitis |
9.5% |
| Neuropathy Peripheral |
7.6% |
| Rash |
5.7% |
| Urticaria |
5.7% |
| Diarrhoea |
5.1% |
| Hepatic Encephalopathy |
5.1% |
| Vomiting |
5.1% |
| Venous Thrombosis Limb |
4.4% |
| Xerosis |
3.8% |
| Interstitial Lung Disease |
3.2% |
| Skin Toxicity |
3.2% |
| Varices Oesophageal |
3.2% |
| Abdominal Pain |
2.5% |
| Acne |
2.5% |
| Dermatitis Acneiform |
2.5% |
| Haemoptysis |
2.5% |
| Skin Ulcer |
2.5% |
| Supraventricular Tachycardia |
2.5% |
|
| Concomitant |
| Rectal Cancer Metastatic |
21.8% |
| Colorectal Cancer |
20.2% |
| Colon Cancer |
14.5% |
| Colon Cancer Metastatic |
6.5% |
| Colorectal Cancer Metastatic |
5.6% |
| Nausea |
4.0% |
| Pain |
4.0% |
| Product Used For Unknown Indication |
4.0% |
| Head And Neck Cancer |
2.4% |
| Rectal Cancer |
2.4% |
| Breast Cancer Metastatic |
1.6% |
| Cancer Pain |
1.6% |
| Lung Neoplasm Malignant |
1.6% |
| Metastases To Large Intestine |
1.6% |
| Muscle Tightness |
1.6% |
| Pancreatic Carcinoma |
1.6% |
| Premedication |
1.6% |
| Tension Headache |
1.6% |
| Colon Cancer Metastatic |
0.8% |
| Convulsion |
0.8% |
|
| Disease Progression |
15.6% |
| Vomiting |
12.5% |
| Ileus Paralytic |
6.3% |
| Rash |
6.3% |
| Suffocation Feeling |
6.3% |
| Vascular Test Abnormal |
6.3% |
| Wound |
6.3% |
| Adverse Reaction |
3.1% |
| Anaemia |
3.1% |
| Anaphylactic Reaction |
3.1% |
| Brain Neoplasm |
3.1% |
| Chills |
3.1% |
| Colitis Ischaemic |
3.1% |
| Death |
3.1% |
| Hepatic Cirrhosis |
3.1% |
| Hiccups |
3.1% |
| Hypersensitivity |
3.1% |
| Hypomagnesaemia |
3.1% |
| Ileal Fistula |
3.1% |
| Intestinal Obstruction |
3.1% |
|
